Frequency of Metabolic Syndrome in Down Syndrome Patients
Prevalence of Metabolic Syndrome in Down Syndrome Patients
Sponsor: Universidad de Guanajuato
Listed as NCT00864461, this observational or N/A phase trial focuses on Down Syndrome and Metabolic Syndrome X and remains completed. Sponsored by Universidad de Guanajuato, it has been updated 12 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jun 2017 — Aug 2017 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Jun 2017 [monthly]
Unknown Status NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universidad de Guanajuato
For direct contact, visit the study record on ClinicalTrials.gov .